Nerve Growth Factor Market Report 2026

Nerve Growth Factor Market Overview

• Nerve Growth Factor market size has reached to $1.19 billion in 2025 • Expected to grow to $1.71 billion in 2030 at a compound annual growth rate (CAGR) of 7.6% • Growth Driver: Increasing Prevalence Of Neurological Disorders Driving Growth In The Market Due To Advancements In Diagnosis And Neural Repair Therapies • Market Trend: Rising Investment In NGF-Targeting Biologics Strengthens Innovation In Chronic Pain Management • Asia-Pacific was the largest region in 2025.

What Is Covered Under Nerve Growth Factor Market?

Nerve growth factor (NGF) is a type of protein that is essential for the growth, maintenance, and survival of nerve cells, particularly sensory and sympathetic neurons. It plays a crucial role in the development of the nervous system and helps promote the regeneration of nerve cells after injury. Nerve growth factor binds to specific receptors on nerve cells, triggering pathways that support cell survival and differentiation The main types of nerve growth factor are alpha-nerve growth factor (NGF), beta-nerve growth factor (NGF), gamma-nerve growth factor (NGF), others. Alpha-NGF is a protein essential for neuron growth, survival, and peripheral nervous system development. It includes different agents such as cenegermin and others for various indications, including neurodegenerative disorders, spinal cord injuries, eye disorders, epithelial diseases, tissue healing, and others. It is distributed through several distribution channels, such as hospital pharmacy, online pharmacy, and retail pharmacy, and used by several end users, including hospitals, home care, specialty clinics, and others.

What Is The Nerve Growth Factor Market Growth Forecast?

The nerve growth factor market size is expected to see strong growth in the next few years. It will grow to $1.71 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to rising incidence of neurodegenerative diseases, expansion of regenerative medicine programs, increasing clinical trials for nerve repair, growth in biologics R&D funding, innovation in NGF delivery systems. Major trends in the forecast period include increasing research in neuroregeneration therapies, rising focus on neurodegenerative disease treatment, expansion of recombinant protein therapeutics, growing clinical use in ophthalmic disorders, increased investment in nerve repair technologies.

Global Nerve Growth Factor Market Segmentation

1) By Type: Alpha-Nerve Growth Factor (NGF), Beta-Nerve Growth Factor (NGF), Gamma-Nerve Growth Factor (NGF), Other Types 2) By Agents: Cenegermin, Other Agents 3) By Indication: Neurodegenerative Disorders, Spinal Cord Injuries, Eye Disorders, Epithelial Diseases, Tissue Healing, Other Indications 4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy 5) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users Subsegments: 1) By Alpha-Nerve Growth Factor (α-NGF): Natural Alpha-NGF, Recombinant Alpha-NGF, Synthetic Alpha-NGF, Alpha-NGF For Research Applications 2) By Beta-Nerve Growth Factor (β-NGF): Human Beta-NGF, Animal-Derived Beta-NGF, Recombinant Beta-NGF, Therapeutic Beta-NGF, Research-Grade Beta-NGF 3) By Gamma-Nerve Growth Factor (γ-NGF): Natural Gamma-NGF, Recombinant Gamma-NGF, Synthetic Gamma-NGF, Gamma-NGF for Neurodegenerative Research 4) By Other Types: Hybrid NGF Molecules, NGF Mimetics, NGF Gene Therapy-Based Products, NGF-Infused Biomaterials

What Is The Driver Of The Nerve Growth Factor Market?

The increasing prevalence of neurological disorders is expected to propel the growth of the nerve growth factor market going forward. Neurological disorders are medical conditions affecting the brain, spinal cord, and nerves caused by structural, biochemical, or electrical abnormalities. The increasing prevalence of neurological disorders is due to aging populations and advances in diagnostic technology. Advances in diagnostic technology improve the detection and reporting of these disorders, leading to higher documented incidence rates. Nerve growth factor (NGF) plays a crucial role in the maintenance, survival, and regeneration of neurons, making it a key factor in addressing the prevalence of neurological disorders by promoting neural repair and potentially slowing disease progression. For instance, in September 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, dementia (a neurological disorder ) cases in Australia are projected to rise from around 411,100 in 2023 to 849,300 by 2058. Therefore, the increasing prevalence of neurological disorders is driving the growth of the nerve growth factor industry.

Key Players In The Global Nerve Growth Factor Market

Major companies operating in the nerve growth factor market are Dompé farmaceutici S.p.A., Regeneron Pharmaceuticals Inc., Mimetogen Pharmaceuticals, MimeTech Srl, Herantis Pharma, PainCeptor Pharma, Beike Biotechnology, Akeso Inc., Promega Corporation, Enzo Life Sciences Inc., Alomone Labs, Prospec-Tany Technogene Ltd., CUSABIO Technology LLC, Genexis Biotech Pvt. Ltd., Staidson Beijing BioPharmaceuticals, Biomol GmbH, Sino Biological Inc., PeproTech Inc., Abcam plc, Creative BioMart Inc.

Global Nerve Growth Factor Market Trends and Insights

Major companies operating in the nerve growth factor market are focusing on developing NGF-targeting biologic therapies, such as anti-NGF monoclonal antibodies designed to inhibit NGF activity and reduce chronic pain. An anti-NGF monoclonal antibody binds to nerve growth factor and prevents it from activating its receptors, which helps reduce pain signaling and inflammatory responses in patients with degenerative or neuropathic conditions. For instance, in May 2023, Jiangsu Hengrui Pharmaceuticals, a China-based biopharmaceutical company, introduced SHR-1314, a next-generation anti-NGF monoclonal antibody registered for clinical evaluation in patients with osteoarthritis-related pain. The therapy features a highly selective binding profile that reduces NGF-mediated sensitization and a long serum half-life that supports less frequent dosing, and it aims to deliver sustained pain reduction for individuals with chronic joint disease.

What Are Latest Mergers And Acquisitions In The Nerve Growth Factor Market?

In June 2023, Dompé farmaceutici S.p.A., an Italy-based manufacturer of the first recombinant human nerve growth factor, partnered with FarmaMondo Group to expand access to Oxervate (cenegermin). With this partnership, FarmaMondo is the exclusive distributor of Oxervate in select countries, increasing access to this treatment for neurotrophic keratitis patients outside the U.S., Canada, Italy, China, and Switzerland. FarmaMondo Group is a Switzerland-based pharmaceutical services provider specializing in specialty care services for rare diseases.

Regional Insights

Asia-Pacific was the largest region in the nerve growth factor market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Nerve Growth Factor Market?

The nerve growth factor market consists of sales of nerve growth factor protein supplements, nerve growth factor enriched cell culture media, nerve growth factor biomarker detection kits, and diagnostic assays. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Nerve Growth Factor Market Report 2026?

The nerve growth factor market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the nerve growth factor industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.